Eli Lilly | LLY - Ebit





Ebit Zmiana Data
AbbVie USD 6.88B 156M 2026-09
Abbott USD 1.36B 775M 2026-09
ALKERMES USD 36.59M 102.52M 2026-09
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Baxter International USD 314M 38M 2026-09
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Drreddys Laboratories INR 13.52B 10.47B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.15B 157M 2026-09
J&J USD 6.47B 1B 2026-09
Medtronic USD 1.84B 254M 2026-06
Merck USD 7.33B 6.49B 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 5.14B 411M 2026-09
Novartis USD 1.78B 2.4B 2026-09
Novo Nordisk DKK 33.76B 25.86B 2026-06
Perrigo USD 27.2M 116.6M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
Sanofi EUR 1.12B 1.06B 2026-06
United Therapeutics USD 375.6M 49.8M 2026-06
Zoetis USD 1.12B 279M 2026-06